Detalles de la búsqueda
1.
Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study.
Br J Cancer
; 128(1): 21-29, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289372
2.
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
BMC Cancer
; 22(1): 1150, 2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36348385
3.
Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study.
World J Surg Oncol
; 20(1): 46, 2022 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35197061
4.
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19).
Int J Gynecol Cancer
; 31(6): 914-919, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33020205
5.
Dynamic Treatment Stratification Using ctDNA.
Recent Results Cancer Res
; 215: 263-273, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605234
6.
Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy.
Ultrastruct Pathol
; 43(6): 237-247, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31810413
7.
CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.
Histopathology
; 72(2): 259-269, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28795418
8.
Non-bacterial thrombotic endocarditis in ROS1-rearranged lung cancer: a report of two cases.
Transl Lung Cancer Res
; 13(1): 179-185, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38404995
9.
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Clin Transl Oncol
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512450
10.
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer.
Front Oncol
; 13: 1225646, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37927472
11.
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
J Thorac Oncol
; 18(2): 181-193, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36307040
12.
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Clin Transl Oncol
; 25(7): 2090-2098, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708371
13.
Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.
Lung Cancer
; 181: 107257, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263182
14.
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting.
Cancers (Basel)
; 14(18)2022 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139574
15.
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial.
Cancers (Basel)
; 14(10)2022 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625997
16.
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade.
J Immunother Cancer
; 10(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577503
17.
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC.
JTO Clin Res Rep
; 2(1): 100115, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589976
18.
Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma.
Arch Bronconeumol (Engl Ed)
; 57(5): 323-329, 2021 May.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-32253118
19.
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage.
J Chemother
; 33(1): 32-39, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33267748
20.
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 5: 93-102, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994593